Brief: Eterna Therapeutics Acquires Allogeneic Immuno-Oncology Platform From Exacis Biotherapeutics

Ernexa Therapeutics

02/05/2023 12:34

May 2 (Reuters) - Eterna Therapeutics Inc  ERNA.O :
    * ETERNA THERAPEUTICS ACQUIRES ALLOGENEIC IMMUNO-ONCOLOGY
PLATFORM
FROM EXACIS BIOTHERAPEUTICS
    * ETERNA THERAPEUTICS - DEAL TERMS INCLUDE UPFRONT PAYMENT
IN
SHARES OF ETERNA STOCK,  MILESTONE AND OTHER POTENTIAL PAYMENTS
TOTALING UP TO $49.0 MILLION

Source text for Eikon:  ID:nGNX4n3M2d 
Further company coverage:  ERNA.O 

 ((Reuters.Briefs@thomsonreuters.com;))